2 studies found for:    rHIgM22
Show Display Options
Rank Status Study
1 Recruiting An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Condition: Multiple Sclerosis, Acute Relapsing
Interventions: Drug: rHIgM22;   Drug: Placebo
2 Completed An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: rHIgM22

Indicates status has not been verified in more than two years